These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 23671649)
21. A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support. Vangsted AJ; Klausen TW; Gimsing P; Andersen NF; Abildgaard N; Gregersen H; Vogel U Haematologica; 2009 Sep; 94(9):1274-81. PubMed ID: 19734419 [TBL] [Abstract][Full Text] [Related]
22. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Oliver J; Gómez-García M; Paco L; López-Nevot MA; Piñero A; Correro F; Martín L; Brieva JA; Nieto A; Martín J Inflamm Bowel Dis; 2005 Jun; 11(6):576-9. PubMed ID: 15905705 [TBL] [Abstract][Full Text] [Related]
23. IS -94INS/DELATTG POLYMORPHISM IN THE NUCLEAR FACTOR KAPPA-B1 GENE (NFKB1) ASSOCIATED WITH NECROTIZING ENTEROCOLITIS? Ferdinando DLT; Fraga FDCB; Piatto VB; Souza AS Arq Bras Cir Dig; 2023; 35():e1717. PubMed ID: 36629694 [TBL] [Abstract][Full Text] [Related]
24. No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region. Lehnerdt GF; Bankfalvi A; Grehl S; Adamzik M; Lang S; Schmid KW; Siffert W; Riemann K Int J Immunopathol Pharmacol; 2008; 21(4):827-32. PubMed ID: 19144268 [TBL] [Abstract][Full Text] [Related]
25. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970 [TBL] [Abstract][Full Text] [Related]
26. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Adamzik M; Frey UH; Rieman K; Sixt S; Beiderlinden M; Siffert W; Peters J Intensive Care Med; 2007 Jul; 33(7):1199-1203. PubMed ID: 17468848 [TBL] [Abstract][Full Text] [Related]
27. NFKB1-94ins/del polymorphism is not associated with lung injury after cardiopulmonary bypass. Wang JF; Bian JJ; Wan XJ; Zhu KM; Sun ZZ; Lu AD Anaesthesia; 2010 Feb; 65(2):158-62. PubMed ID: 19995347 [TBL] [Abstract][Full Text] [Related]
28. NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome. Jin SY; Luo JY; Li XM; Liu F; Ma YT; Gao XM; Yang YN Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910844 [TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population. Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107 [TBL] [Abstract][Full Text] [Related]
30. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility. Luo YQ; Wang D; Gong T; Zhu J Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002 [TBL] [Abstract][Full Text] [Related]
31. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC. Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711 [TBL] [Abstract][Full Text] [Related]
32. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684 [TBL] [Abstract][Full Text] [Related]
33. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer. Oltulu YM; Coskunpinar E; Ozkan G; Aynaci E; Yildiz P; Isbir T; Yaylim I Biomed Res Int; 2014; 2014():530381. PubMed ID: 24707489 [TBL] [Abstract][Full Text] [Related]
34. Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Riemann K; Becker L; Struwe H; Rübben H; Eisenhardt A; Siffert W Int J Clin Pharmacol Ther; 2007 Aug; 45(8):423-30. PubMed ID: 17725175 [TBL] [Abstract][Full Text] [Related]
35. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Lo SS; Chen JH; Wu CW; Lui WY Surgery; 2009 Mar; 145(3):280-5. PubMed ID: 19231580 [TBL] [Abstract][Full Text] [Related]
36. The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients. Szamosi T; Lakatos PL; ; Szilvasi A; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szabo O; Satori A; Tulassay Z; Miheller P; Horvath HC; Papp J; Tordai A; Andrikovics H Dig Dis Sci; 2009 Feb; 54(2):351-9. PubMed ID: 18716880 [TBL] [Abstract][Full Text] [Related]
37. A functional polymorphism of the NFKB1 gene increases the risk for alcoholic liver cirrhosis in patients with alcohol dependence. Marcos M; Pastor I; González-Sarmiento R; Laso FJ Alcohol Clin Exp Res; 2009 Nov; 33(11):1857-62. PubMed ID: 19673747 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer. Nian X; Zhang W; Li L; Sun Y; Sun E; Han R Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017 [TBL] [Abstract][Full Text] [Related]
39. The Pro-Inflammatory Deletion Allele of the NF-κB1 Polymorphism Is Characterized by a Depletion of Subunit p50 in Sepsis. Marko B; Heurich P; Thon P; Zimmer F; Bergmann L; Nowak H; Rump K; Koos B; Adamzik M; Unterberg M; Rahmel T Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886907 [TBL] [Abstract][Full Text] [Related]
40. Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. Zhou B; Rao L; Peng Y; Wang Y; Li Y; Gao L; Chen Y; Xue H; Song Y; Liao M; Zhang L BMC Med Genet; 2009 May; 10():47. PubMed ID: 19480714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]